Skip to content

Author

M. Andrade

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

The relationship between tumor-infiltrating lymphocytes, pathologic complete response, and event-free survival in patients with early-stage triple-negative breast cancer treated with the KEYNOTE-522 regimen in a real-world scenario

Introduction: Tumor-infiltrating lymphocytes (TILs) are established prognostic and predictive biomarkers in early-stage triple-negative breast cancer (eTNBC). The addition of pembrolizumab to neoadjuvant chemotherapy (NAC) improves outcomes, as demonstrated in the KEYNOTE-522 trial. The role of TILs in this setting war...

R. Bonadio, M. Monteiro, W. Lima et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.